Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety
Launched by JOHNS HOPKINS UNIVERSITY · Jan 24, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety," is studying new tools to improve care for patients with tracheostomies, which are openings in the neck that help people breathe. The trial will test a special kit called the NextGen Tracheostomy Toolkit, which includes advanced robotic devices for suctioning (cleaning the airway) and a mixed reality system to help change tracheostomy tubes. Researchers want to see if using these new tools makes suctioning and tube changes safer and more successful compared to standard care.
To participate in the trial, you must be an adult (18 years or older) who currently has a tracheostomy from a recent hospital stay. The trial will randomly assign participants into four different groups: one will use the robotic suction device, another will use the mixed reality system for tube changes, a third will use both new tools, and a control group will receive regular care. While the trial is not yet recruiting participants, it aims to learn how these innovative techniques can help improve airway safety for those with tracheostomies.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adult patients 18 years or older
- • those who received a tracheostomy during their hospital stay
- • those who were admitted to the hospital with a tracheostomy
- Exclusion Criteria:
- • none
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Ann Arbor, Michigan, United States
Patients applied
Trial Officials
Vinciya Pandian, PhD, MBA, MSN, RN, ACNP-BC
Principal Investigator
Johns Hopkins University School of Nursing
Michael J Brenner, MD, FACS
Principal Investigator
University of Michigan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported